233 related articles for article (PubMed ID: 18761444)
1. Inhibition of class A beta-lactamases by carbapenems: crystallographic observation of two conformations of meropenem in SHV-1.
Nukaga M; Bethel CR; Thomson JM; Hujer AM; Distler A; Anderson VE; Knox JR; Bonomo RA
J Am Chem Soc; 2008 Sep; 130(38):12656-62. PubMed ID: 18761444
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor-resistant class A beta-lactamases: consequences of the Ser130-to-Gly mutation seen in Apo and tazobactam structures of the SHV-1 variant.
Sun T; Bethel CR; Bonomo RA; Knox JR
Biochemistry; 2004 Nov; 43(44):14111-7. PubMed ID: 15518561
[TBL] [Abstract][Full Text] [Related]
3. Ultrahigh resolution structure of a class A beta-lactamase: on the mechanism and specificity of the extended-spectrum SHV-2 enzyme.
Nukaga M; Mayama K; Hujer AM; Bonomo RA; Knox JR
J Mol Biol; 2003 Apr; 328(1):289-301. PubMed ID: 12684014
[TBL] [Abstract][Full Text] [Related]
4. Perturbing the general base residue Glu166 in the active site of class A β-lactamase leads to enhanced carbapenem binding and acylation.
Pan X; Wong WT; He Y; Jiang Y; Zhao Y
Biochemistry; 2014 Aug; 53(33):5414-23. PubMed ID: 25020031
[TBL] [Abstract][Full Text] [Related]
5. Exploring the inhibition of CTX-M-9 by beta-lactamase inhibitors and carbapenems.
Bethel CR; Taracila M; Shyr T; Thomson JM; Distler AM; Hujer KM; Hujer AM; Endimiani A; Papp-Wallace K; Bonnet R; Bonomo RA
Antimicrob Agents Chemother; 2011 Jul; 55(7):3465-75. PubMed ID: 21555770
[TBL] [Abstract][Full Text] [Related]
6. KPC-2 β-lactamase enables carbapenem antibiotic resistance through fast deacylation of the covalent intermediate.
Mehta SC; Furey IM; Pemberton OA; Boragine DM; Chen Y; Palzkill T
J Biol Chem; 2021; 296():100155. PubMed ID: 33273017
[TBL] [Abstract][Full Text] [Related]
7. Carbapenems and SHV-1 beta-lactamase form different acyl-enzyme populations in crystals and solution.
Kalp M; Carey PR
Biochemistry; 2008 Nov; 47(45):11830-7. PubMed ID: 18922024
[TBL] [Abstract][Full Text] [Related]
8. The basis for carbapenem hydrolysis by class A β-lactamases: a combined investigation using crystallography and simulations.
Fonseca F; Chudyk EI; van der Kamp MW; Correia A; Mulholland AJ; Spencer J
J Am Chem Soc; 2012 Nov; 134(44):18275-85. PubMed ID: 23030300
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of proton transfer in class A β-lactamase catalysis and inhibition by avibactam.
Pemberton OA; Noor RE; Kumar M V V; Sanishvili R; Kemp MT; Kearns FL; Woodcock HL; Gelis I; Chen Y
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5818-5825. PubMed ID: 32123084
[TBL] [Abstract][Full Text] [Related]
10. Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem.
Pernot L; Frénois F; Rybkine T; L'Hermite G; Petrella S; Delettré J; Jarlier V; Collatz E; Sougakoff W
J Mol Biol; 2001 Jul; 310(4):859-74. PubMed ID: 11453693
[TBL] [Abstract][Full Text] [Related]
11. Structures of SHV-1 β-lactamase with penem and penam sulfone inhibitors that form cyclic intermediates stabilized by carbonyl conjugation.
Ke W; Pattanaik P; Bethel CR; Sheri A; Buynak JD; Bonomo RA; van den Akker F
PLoS One; 2012; 7(11):e49035. PubMed ID: 23145056
[TBL] [Abstract][Full Text] [Related]
12. Raman crystallographic studies of the intermediates formed by Ser130Gly SHV, a beta-lactamase that confers resistance to clinical inhibitors.
Helfand MS; Taracila MA; Totir MA; Bonomo RA; Buynak JD; van den Akker F; Carey PR
Biochemistry; 2007 Jul; 46(29):8689-99. PubMed ID: 17595114
[TBL] [Abstract][Full Text] [Related]
13. Novel inhibition mechanism of carbapenems on the ACC-1 class C β-lactamase.
Bae DW; Jung YE; Jeong BG; Cha SS
Arch Biochem Biophys; 2020 Oct; 693():108570. PubMed ID: 32888908
[TBL] [Abstract][Full Text] [Related]
14. Interactions of meropenem, with beta-lactamases, including enzymes with extended-spectrum activity against third-generation cephalosporins.
Labia R; Morand A; Tiwari K; Sirot D; Chanal C
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():219-23. PubMed ID: 2808209
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of class A and class C beta-lactamases by penems: crystallographic structures of a novel 1,4-thiazepine intermediate.
Nukaga M; Abe T; Venkatesan AM; Mansour TS; Bonomo RA; Knox JR
Biochemistry; 2003 Nov; 42(45):13152-9. PubMed ID: 14609325
[TBL] [Abstract][Full Text] [Related]
16. Strategic design of an effective beta-lactamase inhibitor: LN-1-255, a 6-alkylidene-2'-substituted penicillin sulfone.
Pattanaik P; Bethel CR; Hujer AM; Hujer KM; Distler AM; Taracila M; Anderson VE; Fritsche TR; Jones RN; Pagadala SR; van den Akker F; Buynak JD; Bonomo RA
J Biol Chem; 2009 Jan; 284(2):945-53. PubMed ID: 18955486
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the SHV-1 beta-lactamase by sulfones: crystallographic observation of two reaction intermediates with tazobactam.
Kuzin AP; Nukaga M; Nukaga Y; Hujer A; Bonomo RA; Knox JR
Biochemistry; 2001 Feb; 40(6):1861-6. PubMed ID: 11327849
[TBL] [Abstract][Full Text] [Related]
18. Clavulanic acid inactivation of SHV-1 and the inhibitor-resistant S130G SHV-1 beta-lactamase. Insights into the mechanism of inhibition.
Sulton D; Pagan-Rodriguez D; Zhou X; Liu Y; Hujer AM; Bethel CR; Helfand MS; Thomson JM; Anderson VE; Buynak JD; Ng LM; Bonomo RA
J Biol Chem; 2005 Oct; 280(42):35528-36. PubMed ID: 15987690
[TBL] [Abstract][Full Text] [Related]
19. Avibactam and inhibitor-resistant SHV β-lactamases.
Winkler ML; Papp-Wallace KM; Taracila MA; Bonomo RA
Antimicrob Agents Chemother; 2015 Jul; 59(7):3700-9. PubMed ID: 25691639
[TBL] [Abstract][Full Text] [Related]
20. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
